Role of Orai3 in the Pathophysiology of Cancer

Jose Sanchez-Collado1, Isaac Jardin1, Jose J López1

  • 1Cell Physiology Research Group, Department of Physiology, Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, 10003 Caceres, Spain.

Insights

The Orai3 calcium channel is overexpressed in cancer, influencing cell growth and survival. This review details Orai3

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The Orai3 channel is a mammalian-exclusive calcium channel involved in two distinct calcium currents: store-operated current (Icrac) and store-independent arachidonic acid (AA)-regulated current (Iarc).
  • Orai3 interacts with stromal interaction molecules (STIM) and other Orai proteins (Orai1/Orai2) in calcium influx pathways.
  • Orai3 overexpression is observed in various cancer cells and tissues compared to normal counterparts.

Purpose of the Study:

  • To review the current understanding of Orai3's functional role in cancer pathogenesis.
  • To explore the cell-specific relevance of Orai3 in calcium influx across different cancer types.
  • To summarize Orai3's contribution to cancer hallmarks such as proliferation and apoptosis resistance.

Main Methods:

  • Literature review of existing studies on Orai3 function in cancer.
  • Analysis of Orai3 expression patterns in neoplastic versus non-tumor cells.
  • Examination of Orai3's role in specific calcium entry pathways (SOCE, AA-regulated) in various cancers.

Main Results:

  • Orai3's role in store-operated calcium entry (SOCE) is cell-specific: crucial in estrogen receptor-positive breast cancer and non-small cell lung cancer (NSCLC), and modulatory in colorectal and pancreatic cancers.
  • In prostate cancer, Orai3 forms heteromeric channels with Orai1, regulated by AA, reducing SOCE and promoting proliferation.
  • Orai3 overexpression supports key cancer hallmarks including cell cycle progression, proliferation, migration, and resistance to apoptosis.

Conclusions:

  • Orai3 plays a significant, albeit cell-specific, role in the pathogenesis of various cancers.
  • Targeting Orai3 may offer a therapeutic strategy for cancers where it drives proliferation and survival.
  • Further research into Orai3's precise mechanisms in different cancer types is warranted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K